IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trametinib With GSK2141795 in BRAF Wild-type Melanoma
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2015 by Adil Daud, University of California, San Francisco.
Recruitment status was: Active, not recruiting
Recruitment status was: Active, not recruiting
Sponsor:
Adil Daud
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Adil Daud, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01941927
First received: August 30, 2013
Last updated: February 17, 2015
Last verified: February 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2016 |
| Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |